| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 145 |
| 1 | UPADACITINIB | 134 |
| 2 | INFLIXIMAB | 56 |
| 3 | PREDNISONE | 35 |
| 4 | USTEKINUMAB | 34 |
| 5 | VEDOLIZUMAB | 34 |
| 6 | ADALIMUMAB-AATY | 27 |
| 7 | ADALIMUMAB-ADAZ | 27 |
| 8 | ADALIMUMAB-FKJP | 24 |
| 9 | METHOTREXATE SODIUM | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRONE | 1 | 0.0093 |
| 1 | MENADIONE | 1 | 0.0072 |
| 2 | PRUCALOPRIDE SUCCINATE | 1 | 0.0029 |
| 3 | SELEGILINE HYDROCHLORIDE | 1 | 0.0017 |
| 4 | UPADACITINIB | 134 | 0.0016 |
| 5 | ADALIMUMAB-AFZB | 3 | 0.0011 |
| 6 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 7 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| 8 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 9 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 134 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 73 |
| 2 | Corticosteroid [EPC] | 52 |
| 3 | Integrin Receptor Antagonist [EPC] | 34 |
| 4 | Interleukin-12 Antagonist [EPC] | 34 |
| 5 | Interleukin-23 Antagonist [EPC] | 34 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 8 | Proton Pump Inhibitor [EPC] | 16 |
| 9 | Purine Antimetabolite [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 134 | 0.0008 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 3 | Integrin Receptor Antagonist [EPC] | 34 | 0.0004 |
| 4 | Interleukin-12 Antagonist [EPC] | 34 | 0.0003 |
| 5 | Interleukin-23 Antagonist [EPC] | 34 | 0.0003 |
| 6 | GLP-2 Analog [EPC] | 4 | 0.0003 |
| 7 | Bismuth [EPC] | 1 | 0.0002 |
| 8 | Aromatic Amino Acid [EPC] | 10 | 0.0002 |
| 9 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |